Szyman has spoken publicly about how she has personally benefitted from Masimo’s technologies, that include products that ...

Masimo currently trades at $171.97 per share and has shown little upside over the past six months, posting a middling return ...

Let’s take a look at how Masimo (NASDAQ:MASI) and the rest of the patient monitoring stocks fared in Q1. Patient monitoring ...

The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.

Buying $100 In MASI: If an investor had bought $100 of MASI stock 15 years ago, it would be worth $779.18 today based on a ...

Joe Kiani, Founder and ex-CEO of Masimo. Amid ongoing lawsuits between health technology company Masimo and its recently ousted billionaire ex-CEO Joe Kiani, shareholder RTW Investments was ...

Earlier this month, Masimo subpoenaed proxy advisors ISS and Glass Lewis for their private communications with investors about the upcoming proxy contest with activist Politan Capital, according ...

Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after market close. Here’s what investors should know. Masimo beat analysts’ revenue expectations by 1.5% last ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and Masimo's claims are rejected in court. Apple and medical equipment maker ...

Irvine-based Masimo Corp. agreed to sell its Sound United consumer audio business to HARMAN International Industries Inc., a subsidiary of Samsung Electronics Co., for $350 million. The deal is ...

July 8 (Reuters) - Masimo (MASI.O), opens new tab said on Monday a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes ...

Matt Levine is a Bloomberg Opinion columnist. A former investment banker at Goldman Sachs, he was a mergers and acquisitions lawyer at Wachtell, Lipton, Rosen & Katz; a clerk for the U.S. Court of ...